Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Prioritization in comparative effectiveness research: the CANCERGEN Experience.

Thariani R, Wong W, Carlson JJ, Garrison L, Ramsey S, Deverka PA, Esmail L, Rangarao S, Hoban CJ, Baker LH, Veenstra DL; Center for Comparative Effectiveness Research in Cancer Genomics (CANCERGEN).

Med Care. 2012 May;50(5):388-93. doi: 10.1097/MLR.0b013e3182422a3b.

2.

Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.

Esmail LC, Roth J, Rangarao S, Carlson JJ, Thariani R, Ramsey SD, Veenstra DL, Deverka P.

Genet Med. 2013 Feb;15(2):115-22. doi: 10.1038/gim.2012.103. Epub 2012 Oct 4.

3.

Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approach.

Klein G, Gold LS, Sullivan SD, Buist DS, Ramsey S, Kreizenbeck K, Snell K, Loggers ET, Gifford J, Watkins JB, Kessler L.

J Comp Eff Res. 2012 May;1(3):241-55.

4.

Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics.

Carlson JJ, Thariani R, Roth J, Gralow J, Henry NL, Esmail L, Deverka P, Ramsey SD, Baker L, Veenstra DL.

Med Decis Making. 2013 May;33(4):463-71. doi: 10.1177/0272989X13484388.

5.

Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium.

Greenberg CC, Wind JK, Chang GJ, Chen RC, Schrag D.

J Comp Eff Res. 2013 Mar;2(2):117-25. doi: 10.2217/cer.12.80.

PMID:
24236554
6.

Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process.

Deverka PA, Lavallee DC, Desai PJ, Armstrong J, Gorman M, Hole-Curry L, O'Leary J, Ruffner BW, Watkins J, Veenstra DL, Baker LH, Unger JM, Ramsey SD.

J Comp Eff Res. 2012 Jul;1(4):359-70.

7.

Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report.

Krishnan JA, Lindenauer PK, Au DH, Carson SS, Lee TA, McBurnie MA, Naureckas ET, Vollmer WM, Mularski RA; COPD Outcomes-based Network for Clinical Effectiveness and Research Translation.

Am J Respir Crit Care Med. 2013 Feb 1;187(3):320-6. doi: 10.1164/rccm.201206-0994WS. Epub 2012 Nov 15.

8.
9.

Patient and Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned.

Forsythe LP, Ellis LE, Edmundson L, Sabharwal R, Rein A, Konopka K, Frank L.

J Gen Intern Med. 2016 Jan;31(1):13-21. doi: 10.1007/s11606-015-3450-z. Epub 2015 Jul 10.

10.

A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research.

Concannon TW, Fuster M, Saunders T, Patel K, Wong JB, Leslie LK, Lau J.

J Gen Intern Med. 2014 Dec;29(12):1692-701. doi: 10.1007/s11606-014-2878-x. Epub 2014 Jun 4. Review.

11.
12.

A tall order on a tight timeframe: stakeholder perspectives on comparative effectiveness research using electronic clinical data.

Holve E, Lopez MH, Scott L, Segal C.

J Comp Eff Res. 2012 Sep;1(5):441-51. doi: 10.2217/cer.12.47.

PMID:
24236421
13.

Priorities for comparative effectiveness reviews in cardiovascular disease.

Eapen ZJ, McBroom AJ, Gray R, Musty MD, Hadley C, Hernandez AF, Sanders GD.

Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):139-47. doi: 10.1161/CIRCOUTCOMES.111.000046. Epub 2013 Mar 12.

15.

A practice-based tool for engaging stakeholders in future research: a synthesis of current practices.

Guise JM, O'Haire C, McPheeters M, Most C, Labrant L, Lee K, Barth Cottrell EK, Graham E.

J Clin Epidemiol. 2013 Jun;66(6):666-74. doi: 10.1016/j.jclinepi.2012.12.010. Epub 2013 Mar 13. Review.

PMID:
23497857
16.

Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older Patients.

Al-Khatib SM, Gierisch JM, Crowley MJ, Coeytaux RR, Myers ER, Kendrick A, Sanders GD.

J Gen Intern Med. 2015 Dec;30(12):1812-20. doi: 10.1007/s11606-015-3411-6.

17.

Engaging Stakeholders To Identify and Prioritize Future Research Needs [Internet].

O’Haire C, McPheeters M, Nakamoto E, LaBrant L, Most C, Lee K, Graham E, Cottrell E, Guise JM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun.

18.

The project data sphere initiative: accelerating cancer research by sharing data.

Green AK, Reeder-Hayes KE, Corty RW, Basch E, Milowsky MI, Dusetzina SB, Bennett AV, Wood WA.

Oncologist. 2015 May;20(5):464-e20. doi: 10.1634/theoncologist.2014-0431. Epub 2015 Apr 15.

19.

What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.

Trosman JR, Weldon CB, Schink JC, Gradishar WJ, Benson AB 3rd.

J Comp Eff Res. 2013 Jul;2(4):461-77. doi: 10.2217/cer.13.42.

PMID:
24236686
20.

Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.

Goddard KA, Knaus WA, Whitlock E, Lyman GH, Feigelson HS, Schully SD, Ramsey S, Tunis S, Freedman AN, Khoury MJ, Veenstra DL.

Genet Med. 2012 Jul;14(7):633-42. Review.

Supplemental Content

Support Center